(Nasdaq: TNDM) a leading insulin delivery and diabetes technology company, today announced availability of the Tandem t:slim ...

Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk ...

In December 2025, Tandem Diabetes Care announced that its Tandem t:slim mobile app became available in Canada for Android and iOS users, enabling smartphone-based bolus delivery, pump data viewing, ...

The company's challenges might not be insurmountable, but they are serious enough to warrant a healthy dose of skepticism.

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced Health Canada authorization for distribution of the Tandem t:slim mobile ...

Clinical ink, a global life science technology company, announces a collaboration with Tandem Diabetes Care, a leading innovator in automated insulin delivery solutions. This collaboration enables ...

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

Tandem Diabetes Care (Nasdaq:TNDM) announced today that it launched its t:slim mobile application for Android and iOS users in Canada.

Tandem Diabetes Care, Inc.’s TNDM impressive international expansion is expected to bolster growth in the upcoming quarters. The company’s impressive strategic initiatives provide a favorable ...

Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care to integrate (AID) data.

After being announced a few months ago, Qualcomm’s next-gen Snapdragon X2 Elite chips for Windows are set to launch ...

The Lenovo laptops are expected to be powered by the Snapdragon X2 series CPUs, announced at the Snapdragon Summit in ...